Literature DB >> 6299153

Acquired immunodeficiency syndrome with Pneumocystis carinii pneumonia and Mycobacterium avium-intracellulare infection in a previously healthy patient with classic hemophilia. Clinical, immunologic, and virologic findings.

M C Poon, A Landay, E F Prasthofer, S Stagno.   

Abstract

A previously healthy patient with classic hemophilia who was on a home infusion program with factor VIII concentrates developed an acquired immunodeficiency syndrome manifested by a dramatic weight loss (47 kg over 12 months), lassitude, transient thrombocytopenia, and opportunistic infections with Varicella zoster, Pneumocystis carinii, and Mycobacterium avium-intracellulare. The patient was not homosexual and had no history of intravenous drug abuse. Immunologic studies showed a persistent lymphopenia with reversal of helper/suppressor-cytotoxic T-lymphocyte ratios, depression of human natural killer cell function, and in-vitro lymphocyte proliferative responses to mitogens and viral antigens. Serum IgA levels were also elevated. Serum antibodies against cytomegalovirus, herpes simplex viruses 1 and 2, Epstein-Barr virus, Varicella zoster, and hepatitis B virus were shown, suggesting previous infection by these agents. Reactivation of cytomegalovirus infection was suggested by a rising titer of antibodies against cytomegalovirus concurrent with pneumocystis pneumonia, and was confirmed by the growth of this virus in a throat culture 2 months later.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6299153     DOI: 10.7326/0003-4819-98-3-287

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  23 in total

1.  Natural killer cells in intravenous drug abusers with lymphadenopathy syndrome.

Authors:  G Poli; M Introna; F Zanaboni; G Peri; M Carbonari; F Aiuti; A Lazzarin; M Moroni; A Mantovani
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

2.  Immune functions in homosexual men with antibodies to HTLV-III in Finland.

Authors:  K Krohn; A Ranki; J Antonen; S L Valle; J Suni; A Vaheri; C Saxinger; R C Gallo
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

3.  Abnormalities of in vitro immunoglobulin production in apparently healthy haemophiliacs: relationship with alterations of T cell subsets and with HTLV-III seropositivity.

Authors:  R Biagiotti; M G Giudizi; F Almerigogna; M Mazzetti; A Alessi; G F Del Prete; D Rafanelli; M Fiorilli; M Morfini; S Romagnani
Journal:  Clin Exp Immunol       Date:  1986-02       Impact factor: 4.330

4.  The acquired immunodeficiency syndrome (AIDS).

Authors:  F S Rosen
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

Review 5.  The acquired immune deficiency syndrome.

Authors:  A J Pinching
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

6.  Acquired immunodeficiency syndrome in a patient with no known risk factors: a pathological study.

Authors:  A D Burt; G Scott; C R Shiach; C G Isles
Journal:  J Clin Pathol       Date:  1984-04       Impact factor: 3.411

7.  Lymphocyte-reactive antibodies in acquired immune deficiency syndrome.

Authors:  R C Williams; H Masur; T J Spira
Journal:  J Clin Immunol       Date:  1984-03       Impact factor: 8.317

8.  Psychiatric problems of AIDS inpatients at the New York Hospital: preliminary report.

Authors:  S W Perry; S Tross
Journal:  Public Health Rep       Date:  1984 Mar-Apr       Impact factor: 2.792

9.  Infections caused by Mycobacterium avium complex in immunocompromised patients: diagnosis by blood culture and fecal examination, antimicrobial susceptibility tests, and morphological and seroagglutination characteristics.

Authors:  T E Kiehn; F F Edwards; P Brannon; A Y Tsang; M Maio; J W Gold; E Whimbey; B Wong; J K McClatchy; D Armstrong
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

10.  Functional T lymphocyte immune deficiency in a population of homosexual men who do not exhibit symptoms of acquired immune deficiency syndrome.

Authors:  G M Shearer; S M Payne; L J Joseph; W E Biddison
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.